Are comorbidities associated with long-term survival of lung cancer? A population-based cohort study from French cancer registries.

Fiche publication

Date publication

novembre 2018

Journal

BMC cancer

Auteurs

Membres identifiés du Cancéropôle Est :
Pr VELTEN Michel , Dr WORONOFF Anne-Sophie

Tous les auteurs :
Seigneurin A, Delafosse P, Trétarre B, Woronoff AS, Velten M, Grosclaude P, Guizard AV, Lapôtre-Ledoux B, Bara S, Molinié F, Colonna M

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/30419850

Résumé

Survival rates of lung cancer remains poor and the impact of comorbidities on the prognosis is discussed. The objective of this study was to assess if the Charlson Comorbidity Index (CCI) was associated with 8-year survival rates by histological type.